Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of QMF149 vs Mometasone in Persistent Asthma
NCT00941798Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial of indacaterol in asthma (2 arms), sponsored by Novartis. Primary endpoint: Time to First Serious Asthma Exacerbation up to 21 months. Started Jul 2009; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00941798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941798.